| 000 | 00983 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517081438.0 | ||
| 264 | 0 | _c20160505 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a0392-856X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTufan, Fatih | |
| 245 | 0 | 0 |
_aBisphosphonate use and lower risk of incident diabetes mellitus: suggestions for other possible explanations. _h[electronic resource] |
| 260 |
_bClinical and experimental rheumatology _c |
||
| 300 |
_aS24 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarbohydrate Metabolism _xdrug effects |
| 650 | 0 | 4 | _aCausality |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xepidemiology |
| 650 | 0 | 4 |
_aDiphosphonates _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aSelcukbiricik, Ozlem Soyluk | |
| 700 | 1 | _aOzturk, Gulistan Bahat | |
| 773 | 0 |
_tClinical and experimental rheumatology _gvol. 34 _gno. 1 Suppl 95 _gp. S24 |
|
| 999 |
_c25741733 _d25741733 |
||